| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Brian A Gordon | |
| P2860 | cites work | Serum Neurofilament Light Is Elevated Differentially in Older Adults with Uncomplicated Mild Traumatic Brain Injuries | Q92185486 |
| Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum | Q92252802 | ||
| Plasma neurofilament light chain concentration is increased in anorexia nervosa | Q92352901 | ||
| CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia | Q92355021 | ||
| Confounding effect of blood volume and body mass index on blood neurofilament light chain levels | Q92361899 | ||
| Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke | Q92449558 | ||
| Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures | Q92641125 | ||
| Neurofilament light chain as a blood biomarker to differentiate psychiatric disorders from behavioural variant frontotemporal dementia | Q92891960 | ||
| Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study | Q92985206 | ||
| Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment | Q93005980 | ||
| Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches | Q93103206 | ||
| Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS | Q24633692 | ||
| The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury | Q24648646 | ||
| Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments | Q28506520 | ||
| Increased CSF levels of phosphorylated neurofilament heavy protein following bout in amateur boxers | Q28535187 | ||
| Disruption of type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits | Q28586907 | ||
| Intermediate filaments: structure, dynamics, function, and disease | Q29615442 | ||
| Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis | Q30224292 | ||
| Diffusion tensor imaging: concepts and applications | Q30643031 | ||
| Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration | Q33610029 | ||
| Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients | Q34068878 | ||
| Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have increased levels of neurofilament protein in CSF. | Q34402201 | ||
| Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury | Q34452753 | ||
| A structural scaffolding of intermediate filaments in health and disease | Q34453208 | ||
| Neurofilament gene expression: a major determinant of axonal caliber | Q34625359 | ||
| Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia | Q34746995 | ||
| Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. | Q34792280 | ||
| Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis | Q34975529 | ||
| Axonal damage markers in cerebrospinal fluid are increased in ALS. | Q53378093 | ||
| Serum neurofilament light: A biomarker of neuroaxonal injury after ischemic stroke | Q57049032 | ||
| Serum neurofilament light chain in behavioral variant frontotemporal dementia | Q57158113 | ||
| Longitudinal Performance of Plasma Neurofilament Light and Tau in Professional Fighters: The Professional Fighters Brain Health Study | Q57464933 | ||
| Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis | Q57476263 | ||
| Cerebrospinal fluid neurofilament light in suspected sporadic Creutzfeldt-Jakob disease | Q57481706 | ||
| Neurofilaments as biomarkers in neurological disorders | Q57588817 | ||
| Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis | Q57623408 | ||
| Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest | Q58105080 | ||
| Multicentre quality control evaluation of different biomarker candidates for amyotrophic lateral sclerosis | Q58181716 | ||
| Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's disease | Q58613374 | ||
| Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders | Q58763366 | ||
| Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study | Q59744545 | ||
| Significance of CSF NfL and tau in ALS | Q59901889 | ||
| Neurofilament heavy-chain NfHSMI35 in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes | Q60623883 | ||
| Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer’s disease | Q60961744 | ||
| Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy | Q61698739 | ||
| Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke | Q63535271 | ||
| Blood neurofilament light chain as a biomarker of MS disease activity and treatment response | Q64064373 | ||
| Prognostic value of serum neurofilaments in patients with clinically isolated syndromes | Q64261900 | ||
| Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease | Q64264603 | ||
| Neurofilament as a potential biomarker for spinal muscular atrophy | Q64276902 | ||
| Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis | Q64761571 | ||
| Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders | Q64797205 | ||
| Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease | Q64922770 | ||
| Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis. | Q64946685 | ||
| Hereditary hypotrophic axonopathy with neurofilament deficiency in a mutant strain of the Japanese quail | Q67846004 | ||
| Reduced diameter and conduction velocity of myelinated fibers in the sciatic nerve of a neurofilament-deficient mutant quail | Q70759792 | ||
| Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD | Q73816529 | ||
| Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS | Q75205821 | ||
| A highly sensitive electrochemiluminescence immunoassay for the neurofilament heavy chain protein | Q82713594 | ||
| Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis | Q83465728 | ||
| Serum neurofilament concentrations in children with prolonged febrile seizures | Q84729095 | ||
| Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis | Q86613307 | ||
| Neurofilament Light Chain Determination from Peripheral Blood Samples | Q86748852 | ||
| Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis | Q88960884 | ||
| Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis | Q89122496 | ||
| Serum Neurofilament Light Chain Levels in Patients With Presymptomatic Multiple Sclerosis | Q90084271 | ||
| High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS | Q90088600 | ||
| Serum neurofilament heavy chains as early marker of motor neuron degeneration | Q90093473 | ||
| Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease | Q90139959 | ||
| Neurofilament light: A candidate biomarker of presymptomatic amyotrophic lateral sclerosis and phenoconversion | Q90266760 | ||
| Neurofilament relates to white matter microstructure in older adults | Q90418013 | ||
| Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer's disease | Q90588474 | ||
| Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke | Q90836973 | ||
| A Pilot Cross-Sectional Study to Investigate the Biomarker Potential of Phosphorylated Neurofilament-H and Immune Mediators of Disability in Patients With 5 Year Relapsing-Remitting Multiple Sclerosis | Q90931002 | ||
| Serum neurofilament light chain in genetic frontotemporal dementia: a longitudinal, multicentre cohort study | Q91183325 | ||
| Postoperative delirium is associated with increased plasma neurofilament light | Q91698880 | ||
| Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease | Q91784520 | ||
| Increased neurofilament light chain blood levels in neurodegenerative neurological diseases | Q35000781 | ||
| Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker | Q35003970 | ||
| Axonal degeneration and inflammation in acute optic neuritis | Q35482336 | ||
| Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis | Q35537489 | ||
| Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. | Q35686186 | ||
| CSF neurofilament light chain reflects corticospinal tract degeneration in ALS. | Q35935100 | ||
| Neurofilament proteins in neurodegenerative diseases | Q35975762 | ||
| Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss | Q36129196 | ||
| Monomer-polymer equilibria in the axon: direct measurement of tubulin and actin as polymer and monomer in axoplasm | Q36209856 | ||
| CSF neurofilament proteins in the differential diagnosis of dementia | Q36227579 | ||
| Neurofilaments are obligate heteropolymers in vivo | Q36233485 | ||
| Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study | Q36538745 | ||
| Plasma neurofilament light chain predicts progression in progressive supranuclear palsy | Q36639639 | ||
| CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome | Q36840016 | ||
| Serial soluble neurofilament heavy chain in plasma as a marker of brain injury after cardiac arrest | Q36925772 | ||
| Neurofilament light chain: a biomarker for genetic frontotemporal dementia | Q37208495 | ||
| Neurofilament light chain level is a weak risk factor for the development of MS. | Q37265143 | ||
| Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia | Q37304614 | ||
| Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease | Q37307467 | ||
| Serum neurofilament light protein predicts clinical outcome in traumatic brain injury | Q37397309 | ||
| Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder | Q37676938 | ||
| CSF sAPPβ, YKL-40, and neurofilament light in frontotemporal lobar degeneration. | Q38375870 | ||
| Neurofilament as a blood marker for diagnosis and monitoring of primary progressive aphasias | Q38381072 | ||
| Serum neurofilament is associated with progression of brain atrophy and disability in early MS. | Q38381437 | ||
| Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis | Q38682945 | ||
| Phosphorylated neurofilament heavy chain: A biomarker of survival for C9ORF72-associated amyotrophic lateral sclerosis | Q38719337 | ||
| Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa | Q38882174 | ||
| Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease | Q38975869 | ||
| Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease | Q39120758 | ||
| Neurofilaments and Neurofilament Proteins in Health and Disease | Q39217671 | ||
| CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival | Q39469698 | ||
| Serum Neurofilament Light in American Football Athletes Over the Course of a Season | Q40175729 | ||
| CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls | Q40243703 | ||
| Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis. | Q40864697 | ||
| Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients | Q41462389 | ||
| Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression | Q42287644 | ||
| Elevated neurofilament levels in neurological diseases. | Q42450342 | ||
| Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab. | Q44028578 | ||
| CSF neurofilament light chain and tau differentiate multiple system atrophy from Parkinson's disease | Q44422586 | ||
| Neurofilament light chain as an early and sensitive predictor of long-term neurological outcome in patients after cardiac arrest | Q44508621 | ||
| Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome | Q45284798 | ||
| Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis | Q45341922 | ||
| pNfH is a promising biomarker for ALS. | Q46303787 | ||
| Neurofilament light and heavy subunits compared as therapeutic biomarkers in multiple sclerosis | Q46910370 | ||
| The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease | Q46949879 | ||
| Monitoring disease activity in multiple sclerosis using serum neurofilament light protein | Q47144073 | ||
| Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration | Q47165587 | ||
| Monoclonal antibodies selective for low molecular weight neurofilaments. | Q47186756 | ||
| Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival | Q47341318 | ||
| Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis: Neurofilament Light Chain Levels in Definite Subtypes of Disease | Q47424783 | ||
| Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis | Q47572013 | ||
| Serum neurofilament light is sensitive to active cerebral small vessel disease | Q47631966 | ||
| Neurofilament light protein in blood predicts regional atrophy in Huntington disease | Q47841281 | ||
| CSF neurofilament light chain and phosphorylated tau 181 predict disease progression in PSP. | Q47893422 | ||
| Comparison of elevated phosphorylated neurofilament heavy chains in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis | Q48008806 | ||
| CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease | Q48162267 | ||
| The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias | Q48168855 | ||
| A specific ELISA for measuring neurofilament heavy chain phosphoforms | Q48207023 | ||
| Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease | Q48243501 | ||
| CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis | Q48265513 | ||
| Serum neurofilament light chain in patients with acute cerebrovascular events | Q48343364 | ||
| The Serum Phosphorylated Neurofilament Heavy Subunit as a Predictive Marker for Outcome in Adult Patients after Traumatic Brain Injury | Q48473595 | ||
| Serum Neurofilament Light Protein as a Marker for Diffuse Axonal Injury: Results from a Case Series Study | Q48562884 | ||
| Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases | Q48682038 | ||
| CSF neurofilament protein analysis in the differential diagnosis of ALS. | Q48699278 | ||
| Hyperacute detection of neurofilament heavy chain in serum following stroke: a transient sign | Q48986769 | ||
| Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity. | Q49015259 | ||
| Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases | Q49392411 | ||
| Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40. | Q50065238 | ||
| Plasma neurofilament light chain concentration in the inherited peripheral neuropathies | Q50102118 | ||
| Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adults. | Q50591921 | ||
| Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports. | Q50731678 | ||
| Serial CSF sampling in Alzheimer's disease: specific versus non-specific markers. | Q50794881 | ||
| Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and/or parkinsonian disorders. | Q50940972 | ||
| Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease. | Q51004875 | ||
| Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis. | Q51110507 | ||
| Neurofilament light and tau as blood biomarkers for sports-related concussion. | Q52543726 | ||
| Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-β Load and Cognitive Performance in Cognitively Normal Elderly Participants. | Q52598833 | ||
| Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod. | Q53212006 | ||
| Neurofilament protein levels in CSF are increased in dementia. | Q53227032 | ||
| P304 | page(s) | 105-115 | |
| P577 | publication date | 2020-03-06 | |
| P1433 | published in | Current Opinion in Neurobiology | Q15763572 |
| P1476 | title | Neurofilaments in disease: what do we know? | |
| P478 | volume | 61 |
Search more.